- Home
- » Tags
- » Tetrahydrocannabivarin
Top View
- New Approaches and Challenges to Targeting the Endocannabinoid
- Intoxication from the Novel Synthetic Cannabinoids AB-PINACA and ADB-PINACA: a Case Series and Review of the Literature
- Synthetic Cannabinoids Induce Acute Lung Inflammation Via Cannabinoid Receptor 1 Activation
- 161107345.Pdf
- WHO Expert Committee on Drug Dependence Pre-Review ……………
- Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts
- Phytocannabinoids: What Is on the Horizon?
- The Endocannabioids System and Their Implications in Various Disorders
- The Diverse CB1 and CB2 Receptor Pharmacology of Three Plant Cannabinoids: D9-Tetrahydrocannabinol, Cannabidiol and D9-Tetrahydrocannabivarin
- NIH Public Access Author Manuscript Biochem Pharmacol
- Cannabinoid Receptors As Therapeutic Targets for Autoimmune Diseases
- Supporting Information
- Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
- CANNABIDIOL (CBD) Critical Review Report
- Opposition to the Use of Cannabis for PTSD
- Ultra-Pure Synthetic Cannabinoids
- Cbd & Marijuana Derivatives in Medicine
- Pooled Analysis of Three Randomized, Double-Blind, Placebo Controlled Trials with Rimonabant for Smoking Cessation
- Exacerbation of Psychosis Triggered by a Synthetic Cannabinoid in a 70-Year-Old Woman with Parkinson Disease
- CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2
- Spice and K2 Herbal Highs: a Case Series and Systematic Review Of
- The Endocannabinoid System
- Cannabinoid-Induced Behavioral Sensitization in Adolescent Sprague-Dawley Rats
- The Endocannabinoid System – Current Implications for Drug Development
- Cannabinoids: from Pot to Lab Esther Papaseit1,2, Clara Pérez-Mañá1,2, Ana Pilar Pérez-Acevedo1,2, Olga Hladun1,2, M
- Cannabigerol-Rich Extract Elicits Hyperphagia 1
- 37B913c587d4a693816a82cd3c
- Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
- Cannabinoids in Dermatology: a Scoping Review
- Targeting the Endocannabinoid CB1 Receptor to Treat Body
- The Endocannabinoid System: a Target for Cancer Treatment
- Cannabichromene Is a Cannabinoid CB2 Receptor Agonist
- NDSP Catalog 23Rd Edition
- Cannabis: a Toxin-Producing Plant with Potential Therapeutic Uses
- Characterization of Novel Cannabinoid Receptor 2-Selective Agonists at the Biochemical and Cellular Levels: Leads for Therapeutic Agents Ashley M
- Thcv) on Food Reward and Aversion in Healthy Volunteers
- Opioid-Sparing Effect of Cannabinoids: a Systematic Review and Meta-Analysis
- (Thcv) on Food Reward and Aversion in Healthy Volunteers
- Efficacy of Phytocannabinoids in Epilepsy Treatment
- The Abcs of Cannabis
- Cannabinoid Receptor Ligands
- Cannabinoids in Cancer Treatment: Therapeutic Potential and Legislation
- Beyond THC: the New Generation of Cannabinoid Designer Drugs
- Cannabis Clinical Research: Drug Master Files (Dmfs) & Quality Considerations
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (Δ9-THCV) on Diet Induced Obesity in Rats. Sian Carr
- Efficacy and Safety of Cannabidiol And
- Ultra-Pure Cannabinoids
- Arnold Hanuman Deputy Director Colorado District Attorneys' Council
- ICRS2012 PROGRAMME and ABSTRACTS
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(Ut)Annabinoid” System
- LI-00.100 (For Food/Finished Products) LI-00.100 RM (For Raw Materials)
- The Chemistry of Cannabis and Cannabinoids
- 11-Nor-9-Carboxy-∆9-Tetrahydrocannabinol – a Ubiquitous Yet Underresearched Cannabinoid